ADA Scientific Sessions 2026 Abstract

Naturally Derived Fully Human Anti-ACVR2A Antibodies with Superior PK and Functional Benefits for Obesity and Metabolic Disease

Experiments in animalsInterventions

The paper

Santa Clara

ADA Scientific Sessions 2026 Abstract, 5 Jun 2026

Presented at ADA Scientific Sessions 2026, late-breaking 3080-LB

doi.org/10.2337/db26-3080-lb

JCI Insight6 Oct 2026
Antibody reduced fat while preserving lean mass in mice
Cell Metabolism8 Oct 2026
A triple-target drug cut body weight by up to 19.7% in a trial
The New England Journal of Medicine4 Oct 2026
Retatrutide reduces weight and pain in adults with obesity
The New England Journal of Medicine4 Oct 2026
Survodutide reduces weight in adults with diabetes and obesity